Translational research in hormone receptor-negative breast cancer: mechanisms for early metastasis and prognostic surveillance
博士 === 國立陽明大學 === 臨床醫學研究所 === 107 === Background/aims: About one third of breast cancer tumors are categorized as hormone receptor (HR)-negative subtype and do not respond to hormone therapy. The HR-negative breast cancers, including human epidermal growth factor receptor 2 (HER2) positive or triple...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/36p8yu |